Use this form to request a free consultation with a qualified attorney near you.
Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private.
-December 12, 2008
OsmoPrep and Visicol, two prescription medications used prior to colonoscopy procedures in order to clean out the bowels, will have their warning labels revised to include the strictest safety warnings possible, as required by the U.S. Food and Drug Administration (FDA). FDA officials released a statement regarding the new Boxed Warning for these products Dec. 11.
The two drugs — made by Salix Pharmaceuticals — are oral sodium phosphate (OSP) medications. The FDA's statement recommends that over-the-counter (OTC) oral sodium phosphate drugs should not be used for bowel cleansing at all, in part because of the reports to the FDA of an OSP-caused kidney injury known as "acute phosphate nephropathy."
The FDA is requiring Salix to do the following:
The FDA noted that many OTC phosphate drugs — such as Fleet Phospho-soda — are marketed only to treat constipation, but consumers often use them at higher doses to clean the colon. The recent FDA statement noted that "When used for bowel cleansing, these products have the same risks as prescription" drugs.
Dr. Joyce Korvick, director of the FDA’s section overseeing digestive products, said that symptoms of kidney damage may not appear until long after the kidney damage itself has occurred.
Individuals who suffer injuries after taking a defective drug may be eligible to recover compensation for losses including:
(Source: MSNBC)
If you have been harmed by a drug such as Visicol or OsmoPrep, contact us to speak with a defective drug attorney who will evaluate your situation and help you recover compensation for your losses.